France's Cancer Pain Management market is projected to grow from $179.3 Mn in 2022 to $251.1 Mn by 2030, registering a CAGR of 4.3% during the forecast period of 2022-2030. The main factors driving the growth would be government support and initiatives, the aging population, and increasing cancer incidence. The market is segmented by drug type and by disease. Some of the major players include Sanofi (FRA), Ethypharm (FRA), Grunenthal Pharma, Pfizer, Teva Pharmaceuticals, and Abbott.
France's Cancer Pain Management market is projected to grow from $179.3 Mn in 2022 to $251.1 Mn by 2030, registering a CAGR of 4.3% during the forecast period of 2022 - 2030. France spent $227 Bn on healthcare in 2020 or roughly $3,364 per person. In terms of health spending as a proportion of GDP and per person, France has historically fared better than the average for the EU. Prior to 2020, health spending increased at a rate that was relatively similar to that of the economy, but it did so more swiftly in response to the COVID-19 outbreak, which resulted in an 8% decrease in GDP.
Several well-identified acute and chronic pain syndromes are linked to cancer. Gene alterations affecting essential cell-regulatory proteins are the outcome of the complex and possibly lethal condition known as cancer. Such adjustments set off abnormal cell behaviour, which in turn causes unchecked cell growth and the consequent destruction of neighbouring normal tissues. By pressing on bones, nerves, and other areas of the body, these tumours put pressure on the body and cause pain. Cancer pain can also be felt while undergoing active cancer therapy, especially in more advanced stages of the disease.
Market Growth Drivers
The French government has implemented a number of steps to increase access to cancer care, including the creation of cancer centres, the establishment of cancer screening programmes, and the provision of financial aid for patients. The cancer pain management market is anticipated to increase as a result of these activities, the ageing population and increasing cancer incidence in France.
Market Restraints
Despite having a highly developed healthcare system, access to specialised pain management therapy can be limited in France, especially in rural areas. Mainly, cancer pain management therapies have undesirable side effects that discourage patients from seeking care or restrict the usage of specific medications. The cancer pain management market's growth will be impacted by it.
December 2022: Sanofi and Innate Pharma announced the expansion of their partnership, with Sanofi licencing an NK cell engager programme from Innate's ANKETTM (Antibody-based NK Cell Engager Therapeutics) technology that targets B7H3. Additionally, Sanofi will have the choice to add up to two more ANKETTM targets. Sanofi will be in charge of all development, production, and commercialization following candidate selection.
The French National Agency for Safety of Medicines and Health Products (ANSM) and the French National Authority for Health (HAS) are largely responsible for establishing the regulatory framework and healthcare policies for pain treatment in France. These organisations are in charge of establishing requirements for the safe and efficient application of pain management therapies as well as making sure that healthcare practitioners adhere to strict safety and quality requirements.
The National Plan for the Management of Chronic Pain and the construction of pain management clinics around the nation are only two of the policy efforts the French government has implemented to improve the management of chronic pain in France. Additionally, a variety of pain management therapies are covered by the French National Health Insurance System, including prescription drugs, physiotherapy, and some professional consultations. Patients might need to pay out of pocket for some treatments if reimbursement policies don't cover them entirely.
The French National Health Insurance System (NHIS) is the main factor that determines how pain management therapies are reimbursed in France. Prescription drugs, physical therapy, and some professional consultations are among the pain management therapies covered by the NHIS. Although some therapies may require consumers to pay out of pocket, not all treatments are covered.
The French National Authority for Health (HAS), in cooperation with the French National Agency for Safety of Medicines and Health Products (ANSM), determines reimbursement rates for pain management procedures. The HAS also establishes the reimbursement rates for the therapies that are covered by the NHIS.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Drug Type (Revenue, USD Billion):
Non-steroidal anti-inflammatory medicines relieve pain at the site of injury by blocking the cyclooxygenase enzyme, which prevents prostaglandin formation. NSAIDs are a class of medications that includes medications with analgesic, antipyretic, and, at higher doses, anti-inflammatory properties.
By Disease Indication (Revenue, USD Billion):
Based on disease Indication the market is segmented into:
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?